ArticleScientific reports2026
Efficient medical image segmentation using RepSegNet lightweight reparameterized neural network.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Medical image segmentation requires both high accuracy and computational efficiency, especially in resource-constrained environments. This paper introduces RepSegNet, a novel deep-learning model optimized for medical image segmentation. RepSegNet integrates convolutional neural networks with reparameterization techniques, effectively capturing both local and long-range features while simplifying complex structures during inference. Extensive experiments on diverse medical imaging datasets demonstrate RepSegNet’s superior performance over state-of-the-art models in key segmentation metrics. The model’s lightweight architecture ensures scalability and real-time applicability on edge devices, significantly reducing parameters and computational cost during inference. RepSegNet represents a significant advancement in medical image segmentation, offering a robust, efficient, and scalable solution across diverse clinical applications. Its ability to maintain high accuracy while reducing computational demands paves the way for improved diagnostic processes and potential integration into real-time medical imaging systems. Comprehensive ablation studies validate both architectural components, with reparameterization providing 80.5% parameter reduction and MultiPathMobileBlocks contributing 8.7 F1 points average improvement across all medical imaging modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.